News

Uncovered: Foreign Corrupt Practices Act (FCPA) Issues that Pharma, Biotech & Device Companies Face Today

September 28, 2006
The Harrison Conference Center
Plainsboro, NJ

Speakers:

William A. Green III, Managing Partner, T.D. International
Drew A. Harker, Partner, Arnold & Porter LLP
Richard Jacobson, Partner, Arnold & Porter
Shelby Hunt, Associate, Arnold & Porter LLP
Find more content tagged:

Related Content

June 24, 2020
FCA Exposure in the Age of COVID—How to Distance Yourself From Liability
Coronavirus: False Claims Act Webinar
May 28, 2020
Expanding Restrictions on Foreign Investment in US Tech and Telecom: Investors Beware!
Arnold & Porter Webinar
May 18, 2020
Understanding and Leveraging the Defense Production Act
Coronavirus: Government Contracts Webinar
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept